Strategy
Rand Paul
+24%
By Grow
1 Year Historical Return
This strategy tracks equity positions disclosed in Rand Paul's congressional financial filings submitted within 30 days of each trade. The assets distribution and weights are updated when new filings are posted
Novo Nordisk
20%
Eli Lily
20%
AbbVie
20%
Merck
20%
Pfizer
20%
